advertisement
Zhao Y 29
Showing records 1 to 25 | Display all abstracts from Zhao Y105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Zhao Y
Drug Delivery 2022; 29: 613-623
106837 2021 Survey of Keratoplasty Postoperative Steroid Management
Boychev N
Cornea 2023; 42: 1268-1273
106630 Critical Evaluation of Multifunctional Betaxolol Hydrochloride Nanoformulations for Effective Sustained Intraocular Pressure Reduction
Hu J
International Journal of Nanomedicine 2022; 17: 5915-5931
106343 Correlation study of biomechanical changes between diabetic eye disease and glaucoma using finite element model of human eye with different iris-lens channel distances
Yan Y
Medical Engineering and Physics 2022; 109: 103910
105778 Effects of Tafluprost on Ocular Blood Flow
Zhang X
Ophthalmology and therapy 2022; 11: 1991-2003
106343 Correlation study of biomechanical changes between diabetic eye disease and glaucoma using finite element model of human eye with different iris-lens channel distances
Shi H
Medical Engineering and Physics 2022; 109: 103910
105778 Effects of Tafluprost on Ocular Blood Flow
Zhou X
Ophthalmology and therapy 2022; 11: 1991-2003
106837 2021 Survey of Keratoplasty Postoperative Steroid Management
De Arrigunaga S
Cornea 2023; 42: 1268-1273
106630 Critical Evaluation of Multifunctional Betaxolol Hydrochloride Nanoformulations for Effective Sustained Intraocular Pressure Reduction
Li H
International Journal of Nanomedicine 2022; 17: 5915-5931
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Huang C
Drug Delivery 2022; 29: 613-623
105778 Effects of Tafluprost on Ocular Blood Flow
Zhao Y
Ophthalmology and therapy 2022; 11: 1991-2003
106837 2021 Survey of Keratoplasty Postoperative Steroid Management
Zhao Y
Cornea 2023; 42: 1268-1273
106630 Critical Evaluation of Multifunctional Betaxolol Hydrochloride Nanoformulations for Effective Sustained Intraocular Pressure Reduction
Zhao Y
International Journal of Nanomedicine 2022; 17: 5915-5931
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Zhang Z
Drug Delivery 2022; 29: 613-623
106343 Correlation study of biomechanical changes between diabetic eye disease and glaucoma using finite element model of human eye with different iris-lens channel distances
Zhao Y; Cao Y
Medical Engineering and Physics 2022; 109: 103910
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Hong J
Drug Delivery 2022; 29: 613-623
106630 Critical Evaluation of Multifunctional Betaxolol Hydrochloride Nanoformulations for Effective Sustained Intraocular Pressure Reduction
Ke Y
International Journal of Nanomedicine 2022; 17: 5915-5931
105778 Effects of Tafluprost on Ocular Blood Flow
Yang X
Ophthalmology and therapy 2022; 11: 1991-2003
106837 2021 Survey of Keratoplasty Postoperative Steroid Management
Ciolino JB
Cornea 2023; 42: 1268-1273
106630 Critical Evaluation of Multifunctional Betaxolol Hydrochloride Nanoformulations for Effective Sustained Intraocular Pressure Reduction
Rupenthal ID
International Journal of Nanomedicine 2022; 17: 5915-5931
106343 Correlation study of biomechanical changes between diabetic eye disease and glaucoma using finite element model of human eye with different iris-lens channel distances
Xie Z
Medical Engineering and Physics 2022; 109: 103910
105778 Effects of Tafluprost on Ocular Blood Flow
Zhou D
Ophthalmology and therapy 2022; 11: 1991-2003
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Xu J
Drug Delivery 2022; 29: 613-623
106630 Critical Evaluation of Multifunctional Betaxolol Hydrochloride Nanoformulations for Effective Sustained Intraocular Pressure Reduction
Liu H
International Journal of Nanomedicine 2022; 17: 5915-5931
105778 Effects of Tafluprost on Ocular Blood Flow
Chen B
Ophthalmology and therapy 2022; 11: 1991-2003